tm
Seeing Is Believing
tm
Seeing Is Believing
ARTV is currently covered by 1 analysts with an average price target of $12.98. This is a potential upside of $11.3 (672.62%) from yesterday's end of day stock price of $1.68.
Artiva Biotherapeutics, Common Stock's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of ARTV is 100% BUY.
Highest price target for ARTV is $23, Lowest price target is $23, average price target is $23.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 13-Nov-2024. First documented stock forecast 13-Aug-2024.
Currently out of the existing stock ratings of ARTV, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$23
$21.02 (1061.62%)
$23
7 months 5 days ago
(13-Nov-2024)
0/3 (0%)
$11.3 (96.58%)
What is ARTV (Artiva Biotherapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on ARTV (Artiva Biotherapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on ARTV (Artiva Biotherapeutics, Common Stock)?
Which analyst is the currently most bullish on ARTV (Artiva Biotherapeutics, Common Stock)?
